Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 13;14(11):2446-2448.
doi: 10.1093/ckj/sfab147. eCollection 2021 Nov.

Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients

Affiliations

Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients

An S De Vriese et al. Clin Kidney J. .
No abstract available

PubMed Disclaimer

Figures

FIGURE 1:
FIGURE 1:
SARS-CoV-2 (A) anti-S IgG titres, (B) anti-N IgG titres and (C) QuantiFERON response in HD patients with a history of PCR-confirmed SARS-CoV-2 infection that had asymptomatic or mild disease (blue circles) or severe disease (red circles) as a function of the time interval between the lowest cycle threshold value and serum sampling. Anti-S IgG was measured by a chemiluminescent microparticle immunoassay (CMIA) on the ARCHITECT i System (SARS-CoV-2 IgG II Quant assay, Abbott Laboratories, Abbott Park, IL, USA). The cut-off for positivity (dashed line) was 50 AU/mL and the conversion factor to the World Health Organization binding antibody units (BAU/mL) is BAU/mL = 0.142 × AU/mL. Anti-N IgG was measured by a CMIA on the same ARCHITECT i analyser (SARS-CoV-2 IgG assay, Abbott). A signal:cut-off ratio ≥1.4 (dashed line) was interpreted as reactive. The QuantiFERON SARS-CoV-2 test (Qiagen, Venlo, The Netherlands) measures the secretion of interferon-γ by peripheral blood CD4+ and CD8+ lymphocytes upon SARS-CoV-2 glycoprotein stimulation. The threshold for positivity (dashed line) is 0.15 IU/mL.

References

    1. De Vriese AS, Reynders M.. IgG antibodyresponse to SARS-CoV-2 infection and viral RNA persistence in patients on maintenance hemodialysis. Am J Kidney Dis 2020; 76: 440–441 - PMC - PubMed
    1. Sakhi H, Dahmane D, Attias Pet al. . Kinetics of anti-SARS-CoV-2 IgG antibodies in hemodialysis patients six months after infection. J Am Soc Nephrol 2021; 32: 1033–1036 - PMC - PubMed
    1. Clarke CL, Prendecki M, Dhutia Aet al. . Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int 2021; 99: 1470–1477 - PMC - PubMed
    1. Dudreuilh C, Roper T, Breen Cet al. . IgG SARS-CoV-2 antibodies persist at least for 10 months in patients on hemodialysis. Kidney Int Rep 2021; 6: 1961–1964 - PMC - PubMed
    1. Ikizler TA, Coates PT, Rovin BHet al. . Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy. Kidney Int 2021; 99: 1275–1279 - PMC - PubMed